Bavarian Nordic CEO Says Likely To Sell Imvamune Priority Review Voucher

 
• By Sten Stovall

Danish group believes its smallpox vaccine will get approved, generate a transferable priority review voucher, and replace the current US-licensed replicating smallpox vaccine ACAM2000.

Syringe
Bavavian Nordic Set To Reap Valuable Priority Review Voucher • Source: Shutterstock

More from Strategy

More from Business